Liege 2019 Congress Slides

Below you can see a list of speakers that have agreed to share their slides from the Liege 2019 Symposium. They are listed in alphabetical order.


Prof Sarah Baatout Radiobiology unit, SCK, CEN, Mol, Belgium	How to investigate the radiobiological effects of radionuclide therapies: Models, techniques & tools”
Prof Dr Sally F. Barrington Kings College London and Guy’s and St Thomas’ PET Centre, School of Biomedical Engineering and Imaging Sciences, King’s College London, King’s Health Partners, London, UK	PET in non-Hodgkin lymphoma
Dr Anne-Ségolène Cottereau Nuclear Medicine Department, Cochin Hospital, René Descartes University	PET in Hodgkinlymphoma
Dr Julie Cousaert UZ Brussel	New Annex 1 – are we ready?
Dr Benedicte Daenen & Gauthier Namur CHC Liege, Belgium	Chronic back pain management: The value of CT and MRI and the added value of SPECT/CT
Dr Christophe Deroose UZ & KU Leuven	Proper administration of oncological therapeutic radiopharmaceuticals: a systematic approach
Prof Dr Kjell Erlandsson UCL, London, UK	Advances and applications of solid state SPECT cameras
Dr Glenn Flux Royal Marsden Hospital, London, UK	Imaging and dosimetry for molecular radiotherapy – toward multicentre trials.
Prof. Dr med. Luca Giovanella Imaging Institute of Southern Switzerland	Radioiodine therapy in DTC with a discussion of the ATA, ETA, EANM, SNMMI “Martinique Principles”
Prof. Dr med. Luca Giovanella Imaging Institute of Southern Switzerland	Novel aspects in the EANM-SNMMI guidelines on thyroid imaging, radioiodine uptake and therapy in benign diseases
Dr Simon Lacroix CUB-Hopital Erasme	Gallium-68 produced by cyclotron vs generator: pros and cons
Prof. Dr. Marnix M.G.E.H. Lam Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands	Holmium-166 Radioembolization
Prof Dr Cristina Nanni Azienda Ospedaliero Universitaria Policlinico S.Orsola-Malpighi, Bologna, Italy.	Interpretation criteria for FDG PET/CT in multiple myeloma
Dr Mallory Salvé Nuclear Medicine and Oncological Imaging Division, CHU of Liege, Liège, Belgium GIGA‐CRC In VIVO Imaging, University of Liège, Liège, Belgium	Flow chemistry and Chemometrics: an innovative way to optimize the Radiopharmaceutical R&D
Prof Dr Dennis Schaart TU Delft, Delft, Netherlands	Recent developments and future perspectives in PET detector development
Pr Dimitris Visvikis INSERM UMR 1101 LaTIM UBO, Brest, France	Potential of artificial intelligence in medical image processing
Prof Dr Stephan Walrand UCL, Louvain, Belgium	Y90 Post-therapy imaging
Dr Zéna Wimana Institut Jules Bordet	Gallium-68 produced by cyclotron vs generator: pros and cons (for 11:00 – 12:00) and Labelling and dispensing of Therapeutic radiopharmaceuticals (14:00 – 14:30)